Hereditary and Acquired Ichthyosis Vulgaris

Back

Background

Hereditary ichthyosis vulgaris and acquired ichthyosis vulgaris, members of a group of cutaneous disorders of keratinization, appear similar both clinically and histologically. The term ichthyosis is derived from the ancient Greek root ichthys, meaning fish. Although the resemblance is rather fanciful, it nevertheless conveys the characteristic features of these diseases. References to ichthyosis have been found in ancient medical texts aged more than 2000 years. Robert Wilan first made the most accurate description of ichthyosis in the English literature in 1808. Later modifications classified the diseases into hereditary and acquired forms.

Hereditary ichthyosis vulgaris is an autosomal dominant genetic disorder first evident in early childhood. It is the most common form of ichthyosis, accounting for more than 95% of ichthyosis cases. Mutations in genes relating to skin barrier formation produce it.[1] It is often caused by altered profilaggrin expression leading to scaling and desquamation. Visible scales are retained for longer periods and sloughed off in clumps. Hereditary ichthyosis is also associated with atopy. The protein filaggrin is important in maintaining effective skin barrier function. Loss-of-function mutations in the profilaggrin gene (FLG) are evident in up to 10% of the population, causing ichthyosis vulgaris[2] and representing a major risk factor for the development of atopic dermatitis.[3] This discovery, in 2006, represented a marked a breakthrough in the understanding of these disorders.[4] Next-generation sequencing is capable of facilitating diagnosis and determining genetic causes.[1, 5]

Acquired ichthyosis, usually appearing for the first time in adulthood, is a nonhereditary condition associated with internal disease. Acquired ichthyosis is rare and must be viewed as a marker of systemic disease, including malignancy. Cases have been attributed to the use of certain medications. Ichthyosis vulgaris is the most common type of ichthyosis.[6]

Other Medscape Drugs & Diseases articles on ichthyosis include the following:

Pathophysiology

Ichthyosis vulgaris is classified as a retention hyperkeratosis. The only known molecular marker affected by hereditary ichthyosis vulgaris is profilaggrin, a high molecular weight filaggrin precursor. Profilaggrin, synthesized in the granular layer of the epidermis, is a major component of keratohyalin granules. Through various posttranslational modifications, profilaggrin is converted to filaggrin, which aggregates keratin intermediate filaments in the lower stratum corneum. Filaggrin is proteolyzed and metabolized, producing free amino acids that may play a critical role as water-binding compounds in the upper stratum corneum. Normal cycles of skin hydration and dehydration contribute to normal desquamation. These cycles are disrupted in ichthyosis vulgaris.

Normal expression of the profilaggrin gene can be first detected in the granular layer. In ichthyosis vulgaris, the expression of profilaggrin is absent or reduced in the epidermis. This biochemical abnormality correlates with the decreased numbers of keratohyalin granules and the clinical severity of the condition. Analyses of cultured keratinocytes have shown reduced profilaggrin mRNA. Compared with normal amounts, one study found only 50% of the profilaggrin mRNA and 10% of the profilaggrin protein present. Research has shown that defective posttranscriptional regulation leads to decreased stability of profilaggrin mRNA.

The profilaggrin gene is part of a cluster of genes on 1q21 that encodes for structural proteins expressed in terminally differentiating epidermis. This complex, called the epidermal differentiation complex, involves many genes involved in this process. An adjacent region on 1q22 may also be involved.[7, 8] The underlying molecular mechanisms contributing to the pathophysiology of this disease have not yet been determined. Studies are currently underway in humans and mouse models.

An association exists between filaggrin null mutations of ichthyosis vulgaris and atopic dermatitis.[9, 10] Two common filaggrin (FLG) null mutations cause ichthyosis vulgaris and predispose to eczema and secondary allergic diseases. Comprehensive analysis of the gene encoding filaggrin uncovered prevalent and rare mutations in ichthyosis vulgaris and atopic eczema.[11] These common European mutations are ancestral variants carried on conserved haplotypes. Fifteen variants were described, including 7 that are prevalent, all being either nonsense or frameshift mutations that, in representative cases, resulted in loss of filaggrin production in the epidermis.

Filaggrin mutations p.R501X and c.2282del4 were analyzed in patients with ichthyosis vulgaris.[12] Homozygotes and compound heterozygotes may be severely affected, whereas heterozygotes showed mild disease or were asymptomatic, suggesting semidominant inheritance with incomplete penetrance in heterozygotes. The presence of FLG mutations in 15 of 21 ichthyosis vulgaris patients were studied with a marked generalized scaling phenotype, including 8 affected members of a 4-generation family. In this group, heterozygous patients for p.R501X and c.2282del4 also displayed a pronounced phenotype. Filaggrin mutation c.3321delA was identified in a Korean patient with ichthyosis vulgaris and atopic dermatitis.[13] Mutations R501X and 2282del4 represent the most frequent genetic cause in German ichthyosis vulgaris patients, but are probably population and family specific.[14]

Filaggrin mutations were identified in three Chinese pedigrees with ichthyosis vulgaris, two having novel FLG null mutations (c.477-478insA and c.6218-6219delAA) and a known mutation (c.3321delA).[15] The proband of one pedigree was compound heterozygous for these mutations, yet had a mild phenotype. Targeted next-generation sequencing delineated nine novel FLG variants in other Chinese study.[16]

Mutations in the gene encoding filaggrin have been identified as the cause of ichthyosis vulgaris and shown to be major predisposing factors for atopic dermatitis both in European and Japanese populations.[17, 18]

Mutations at any site within FLG appear to cause significant effects, possibly accounting for the lack of genotype-phenotype correlation observed in patients with FLG mutations.[19]

The percentage of mutations in the FLG gene was 74% with isolated ichthyosis vulgaris compared with 43% in patients with atopic dermatitis–associated ichthyosis vulgaris.[20] Thus, it appears factors other than FLG gene mutations can down-regulate profilaggrin/filaggrin expression, leading to the ichthyosiform phenotype in the context of atopic dermatitis. Interestingly, a complete filaggrin deficiency, but not a partial one, is associated with only moderate changes in transepidermal water loss and skin hydration.[21] Thus, some genes linked to atopic dermatitis are not linked with ichthyosis vulgaris. A 2018 study identified 607 atopic dermatitis genes and 193 ichthyosis vulgaris ones as differentially expressed when these atopic or ichthyosis vulgaris patients were compared with healthy donors.[22]

Etiology

Hereditary ichthyosis vulgaris is an autosomal dominant genetic disorder first evident in early childhood. Acquired ichthyosis may represent a paraneoplastic syndrome with an underlying cancer, such as undiagnosed multiple myeloma[23] or reflect a serious underlying disorder such as systemic lupus erythematosus.[24]

Epidemiology

Frequency

United States

Hereditary ichthyosis vulgaris is a common disease in the United States, with a prevalence of approximately 1 case in 300 persons. Because symptoms improve with age, the true prevalence is probably higher. Acquired ichthyosis is extremely rare. Its prevalence in the United States is unknown.

International

Hereditary ichthyosis vulgaris is found worldwide, and the prevalence depends on the location. One study in Berkshire, England, observed a frequency of 1 case in 250 schoolchildren. Acquired ichthyosis is extremely rare. Its prevalence worldwide is unknown.

Race

Hereditary and acquired ichthyosis vulgaris have no known racial predisposition.

Sex

Hereditary and acquired ichthyosis occur equally in men and women.

Age

Hereditary ichthyosis vulgaris typically is absent at birth. It appears in most patients during the first year of life and in the vast majority by age 5 years. The extent of scaling usually intensifies up until puberty and subsequently decreases with age.

Acquired ichthyosis usually first appears in adulthood; however, age-associated systemic diseases do occur in children.

Prognosis

The prognosis for hereditary ichthyosis vulgaris is excellent. Many patients experience improvement of symptoms with age. The prognosis for acquired ichthyosis vulgaris depends on the severity of the underlying systemic disease.

Children and adolescents with hereditary ichthyosis vulgaris may experience some morbidity in terms of cosmesis. Secondary infections may occur in fissures of the hands and feet. The morbidity and mortality of acquired ichthyosis in adults is due to associated internal disease.

History

Hereditary ichthyosis

Although the skin in hereditary ichthyosis vulgaris looks and feels normal at birth, it gradually becomes rough and dry in early childhood. Scaling tends to be most prominent on the extensor surfaces of the extremities and absent on the flexor surfaces.

The diaper area is usually unaffected. The forehead and cheeks may be involved early on, but scaling usually diminishes in these areas with age. A notable amelioration of symptoms occurs during the summer months.

A family history of hereditary ichthyosis vulgaris may be difficult to ascertain because of the varying degrees of penetrance and the general improvement of symptoms over time.

Many hereditary ichthyosis vulgaris patients have associated atopic manifestations (eg, asthma, eczema, hay fever). Atopic conditions can be found in many family members, with or without symptoms of ichthyosis vulgaris. One study noted atopic manifestations in almost half of all subjects enrolled, with 41% having at least one relative who also was affected.

Acquired ichthyosis

Acquired ichthyosis is clinically indistinguishable from hereditary ichthyosis; however, acquired ichthyosis is associated with various systemic diseases.

The appearance of ichthyosis in adulthood can occur before or after the diagnosis of a systemic condition. Disease severity varies depending on the course of the associated systemic condition.

Acquired ichthyosis is associated with many systemic diseases, including cancer (especially lymphoma), primary cutaneous CD30+ lymphoproliferative disorders,[25] and other neoplasms including osseous hemangiopericytoma,[26] sarcoidosis, leprosy, thyroid disease, hyperparathyroidism,[27] nutritional disorders, chronic renal failure, bone marrow transplantation,[28] and HIV infection.[29] Autoimmune diseases, including systemic lupus erythematosus[30] and dermatomyositis,[31] are also linked. It was recently described in a patient with the overlap syndrome consisting of systemic sclerosis and systemic lupus erythematosus.[30]

The types of cancers most often found in association with acquired ichthyosis are Hodgkin disease, non-Hodgkin lymphoma (including mycosis fungoides), myeloma, Kaposi sarcoma, leiomyosarcoma, and carcinomas of the lung, breast, ovary,[32] and cervix.[33]

The use of certain medications has been linked to acquired ichthyosis, namely nicotinic acid,[34, 35] triparanol, butyrophenones, dixyrazine,[36] cimetidine, and clofazimine.[37]

Bathing suit ichthyosis is a striking and unique clinical form of autosomal recessive congenital ichthyosis characterized by marked scaling on the bathing suit areas but sparing of the extremities and the central face. Bathing suit ichthyosis, caused by transglutaminase-1 deficiency, displays evidence that suggests it is a temperature-sensitive phenotype.[38]

Physical Examination

Ichthyosis vulgaris (both hereditary and acquired) is characterized by symmetrical scaling of the skin, which varies from barely visible roughness and dryness to strong horny plates. Note the image below.



View Image

Hereditary ichthyosis vulgaris with thick scaling of the anterior shins.

Scales are small, fine, irregular, and polygonal in shape, often curling up at the edges to give the skin a rough feel. Scales vary in size from 1 mm to 1 cm in diameter and range from white to dirty gray to brown. Dark-skinned individuals often have darker scales. Different types of scaling may be found in different areas, even in the same patient. Most scaling occurs on the extensor surfaces of the extremities, with a sharp demarcation between normal flexural folds and the surrounding affected areas.

The lower extremities generally are more affected than the upper extremities. Compared to other sites, the scales overlying the shins are thicker, darker, and arranged in a mosaic pattern. Patients often report "lizard skin" in these areas during the winter. If the trunk is involved, scaling tends to be more pronounced on the back than on the abdomen. Relative sparing of the face is seen, most likely because of increased sebaceous secretions, although the cheeks and forehead may be involved during early childhood in the hereditary form.

Dry scaling is often observed uniformly over the scalp. Sparing of the flexural folds (eg, neck, axillae, antecubital and popliteal fossae) is attributed to the relative increase in temperature and humidity in these areas. Overall symptoms of ichthyosis vulgaris generally improve in the summer months or in warm climates.

Hyperkeratosis is often present on the palms and soles, causing them to appear dirty. Skin creases in these areas are more prominent and can lead to painful fissuring, especially during dry weather. Secondary infections at fissure sites are common.

Keratosis pilaris (follicular hyperkeratosis) occurs on the side of the cheek and neck, dorsum of the upper arms, buttocks, and thighs. It consists of spiny parafollicular papules that when palpated resemble a cheese grater. Dried skin in the central portion is often white and mistaken for pus. Inflammation may or may not be present. Keratosis pilaris, which can be present without scaling, may be the only finding in family members with hereditary ichthyosis vulgaris. Keratosis pilaris may be linked to an absence of sebaceous glands, which represents an early step in keratosis pilaris pathogenesis.[39]

Pruritus can be caused by dry skin, even if inflammation is not evident. As a result, itching and scratching may lead to erythema in affected areas.

Eyelash trichomegaly, defined as increased length (≥ 12 mm), curling, pigmentation, or thickness of eyelashes, was evaluated. Eyelashes of those with atopic dermatitis and males with ichthyoses vulgaris were found to be significantly longer than those of controls.[40]

Complications

The extremities may fissure and become secondarily infected. Additional complications in acquired ichthyosis depend on the associated systemic disease.

Procedures

Skin biopsy specimens can be examined under light microscopy and electron microscopy. Take biopsy samples from regions of maximal hyperkeratosis because areas of mild scaling are less reliable for histopathologic analysis and findings may be indistinguishable from those of normal skin. The thickest scales are usually found on the anterior aspect of the lower leg.

Histologic Findings

The histological appearance of both hereditary ichthyosis and acquired ichthyosis is practically identical. The stratum corneum shows compact hyperkeratosis, although some areas can be laminated. Follicular plugging may be present and represents associated keratosis pilaris. The granular layer is usually one-layer thick or absent. Ichthyosiform sarcoid, a manifestation of acquired ichthyosis in sarcoid patients, has the additional presence of multiple noncaseating granulomas in the dermis. Note the image below.



View Image

Hematoxylin and eosin staining of acquired ichthyosis vulgaris in an adult. Shows epidermal atrophy with thinning of the granular layer. No dermal inf....

Ultrastructural studies show reduced or absent keratohyalin granules housed in the granular layer. They appear spongy or crumbly, most likely due to defective keratohyalin synthesis. The hyperkeratotic portions of the stratum corneum have a normal keratin pattern.

Medical Care

Hereditary ichthyosis vulgaris is a chronic disorder that may improve with age but often requires continuous therapy. The severity of acquired ichthyosis usually depends on the status of the underlying systemic condition. The main approach to treatment of both conditions includes hydration of the skin and application of an ointment to prevent evaporation. Hydration promotes desquamation by increasing hydrolytic enzyme activity and the susceptibility to mechanical forces. Pliability of the stratum corneum is also improved. Note the following:

Topical retinoids are helpful for some patients.

Alpha-hydroxy acids (eg, lactic, glycolic, or pyruvic acids) are effective for hydrating the skin. They work by causing disaggregation of corneocytes in the lower levels of the newly forming stratum corneum. Lactic acid is available as a 12% ammonium lactate lotion, or it can be compounded by prescription in a concentration of 5-10% in a suitable vehicle. Twice-daily applications have shown to be superior to petrolatum-based creams for controlling of ichthyosis vulgaris.

Removal of scales can be aided by keratolytics (eg, salicylic acid), which induce corneocyte disaggregation in the upper stratum corneum. A commercially available 6% salicylic acid gel can be used on limited areas.

Over-the-counter products often contain urea or propylene glycol. Moisturizers containing urea in lower strengths (10-20%) produce a more pliable stratum corneum by acting as a humectant. Propylene glycol draws water through the stratum corneum by establishing a water gradient. Thick skin is then shed following hydration. Propylene glycol is a common vehicle in both prescription and over-the-counter preparations. A new urea topical formulation applied to hyperkeratotic and dry skin in these patients compared favorably with a standard emollient cream.[45]

A urea-based emulsion composed of 10% urea, ceramides, and natural moisturizing factors used twice daily may be beneficial.[46] Urea helps maintain skin hydration and may have a role in assisting the regulation of epidermal genes used for proper barrier function.[47]

Topical retinoids (eg, tretinoin) may be beneficial. They reduce cohesiveness of epithelial cells, stimulate mitosis and turnover, and suppress keratin synthesis.[48] Tazarotene, a topical receptor-selective retinoid, has also been effective in one small trial.[49]

Ichthyosis vulgaris is not responsive to steroids, but a mild topical steroid may be useful for pruritus.

Acquired ichthyosis vulgaris generally tends to improve with treatment of the underlying systemic condition.

Studies are being designed to quantify and compare the physiochemical properties of various topical emollients with the most desirable attributes to treat ichthyosis vulgaris.[50]

Prevention

In many patients, scaling can be controlled by diligent and consistent treatment.

Medication Summary

The goal of pharmacotherapy is to reduce morbidity and to prevent complications. Because skin barrier defects caused by FLG mutations allows allergens to penetrate the epidermis and to interact with antigen-presenting cells, restoration of skin barrier function with emollients may represent a pivotal prophylactic approach.[51] Patients with atopic dermatitis and ichthyosis vulgaris benefit from therapy with moisturizers.[52]  Topical preparations with glycerin 5-10 %, dexpanthenol 5%, and polyethylene glycol (batch 400) may be valuable in patients with mild scaling.[53]

Tretinoin topical (Retin-A, Avita)

Clinical Context:  Tretinoin is a keratolytic agent that acts by increasing epidermal cell mitosis and turnover while suppressing keratin synthesis.

Tazarotene (Tazorac)

Clinical Context:  Tazarotene is a receptor-selective retinoid that is a synthetic retinoid prodrug that is rapidly converted into tazarotenic acid. Because use of tretinoin is often hampered by its irritancy, this product may be advantageous.

Class Summary

Retinoids decrease the cohesiveness of abnormal hyperproliferative keratinocytes and may reduce the potential for malignant degeneration. They modulate keratinocyte differentiation and have been shown to reduce the risk of skin cancer formation in renal transplant patients.

Ammonium lactate (Lac-Hydrin) 12% cream or lotion

Clinical Context:  Ammonium lactate is an alpha-hydroxy acid that also is a naturally occurring humectant in the skin. It works to moisturize the skin and reduces excessive epidermal keratinization by causing loss of adhesiveness between corneocytes. Ammonium lactate is available over the counter as 12% ammonium lactate lotion (AmLactin Lotion).

Class Summary

Humectants increase skin moisture.

Author

Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Disclosure: Nothing to disclose.

Coauthor(s)

Jason F Okulicz, MD, FACP, FIDSA, Director, HIV Medical Evaluation Unit, Infectious Disease Service, San Antonio Military Medical Center; Associate Professor of Medicine, F Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences; Clinical Associate Professor of Medicine, University of Texas Health Science Center at San Antonio; Adjunct Clinical Instructor, Feik School of Pharmacy, University of the Incarnate Word

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Gilead Sciences.

Specialty Editors

David F Butler, MD, Former Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

Disclosure: Nothing to disclose.

Lester F Libow, MD, Dermatopathologist, South Texas Dermatopathology Laboratory

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Albert C Yan, MD, Section Chief, Associate Professor, Department of Pediatrics, Section of Dermatology, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine

Disclosure: Nothing to disclose.

References

  1. Takeichi T, Akiyama M. Inherited ichthyosis: Non-syndromic forms. J Dermatol. 2016 Mar. 43 (3):242-51. [View Abstract]
  2. Thyssen JP, Godoy-Gijon E, Elias PM. Ichthyosis vulgaris - the filaggrin mutation disease. Br J Dermatol. 2013 Jan 10. [View Abstract]
  3. McGrath JA, Uitto J. The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med. 2008 Jan. 14(1):20-7. [View Abstract]
  4. Brown SJ, McLean WH. One remarkable molecule: filaggrin. J Invest Dermatol. 2012 Mar. 132(3 Pt 2):751-62. [View Abstract]
  5. Gong L, Liu CC, Li YH, Xu XG. Whole exome sequencing identified two point mutations of COL7A1 and FLG in a Chinese family with dystrophic epidermolysis bullous pruriginosa and ichthyosis vulgaris. J Dermatol. 2019 Feb. 46 (2):158-160. [View Abstract]
  6. Seidl-Philipp M, Schatz UA, Gasslitter I, Moosbrugger-Martinz V, Blunder S, Schossig AS, et al. Spectrum of ichthyoses in an Austrian ichthyosis cohort from 2004 to 2017. J Dtsch Dermatol Ges. 2020 Jan. 18 (1):17-25. [View Abstract]
  7. Zhong W, Cui B, Zhang Y, et al. Linkage analysis suggests a locus of ichthyosis vulgaris on 1q22. J Hum Genet. 2003. 48(7):390-2. [View Abstract]
  8. Liu P, Yang Q, Wang X, et al. Identification of a genetic locus for ichthyosis vulgaris on chromosome 10q22.3-q24.2. J Invest Dermatol. 2008 Jun. 128(6):1418-22. [View Abstract]
  9. Hanifin JM. Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. J Invest Dermatol. 2009 Feb. 129(2):320-2. [View Abstract]
  10. Winge MC, Hoppe T, Berne B, Vahlquist A, Nordenskjöld M, Bradley M, et al. Filaggrin genotype determines functional and molecular alterations in skin of patients with atopic dermatitis and ichthyosis vulgaris. PLoS One. 2011. 6(12):e28254. [View Abstract]
  11. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet. 2007 May. 39(5):650-4. [View Abstract]
  12. Gruber R, Janecke AR, Fauth C, Utermann G, Fritsch PO, Schmuth M. Filaggrin mutations p.R501X and c.2282del4 in ichthyosis vulgaris. Eur J Hum Genet. 2007 Feb. 15(2):179-84. [View Abstract]
  13. Kang TW, Lee JS, Oh SW, Kim SC. Filaggrin mutation c.3321delA in a Korean patient with ichthyosis vulgaris and atopic dermatitis. Dermatology. 2009. 218(2):186-7. [View Abstract]
  14. Oji V, Seller N, Sandilands A, et al. Ichthyosis vulgaris: novel FLG mutations in the German population and high presence of CD1a+ cells in the epidermis of the atopic subgroup. Br J Dermatol. 2009 Apr. 160(4):771-81. [View Abstract]
  15. Xiong Z, Luo S, Xu X, Zhang L, Peng H, Li W, et al. Novel FLG mutations associated with ichthyosis vulgaris in the Chinese population. Clin Exp Dermatol. 2012 Mar. 37(2):177-80. [View Abstract]
  16. Chen S, Kong X, Wei X, Sun Y, Yin D, Zhang Q, et al. Targeted next-generation sequencing identifies 9 novel FLG variants in Chinese Han patients with ichthyosis vulgaris. Br J Dermatol. 2017 Apr 13. [View Abstract]
  17. Nomura T, Sandilands A, Akiyama M, et al. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol. 2007 Feb. 119(2):434-40. [View Abstract]
  18. Nomura T, Akiyama M, Sandilands A, et al. Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. J Invest Dermatol. 2008 Jun. 128(6):1436-41. [View Abstract]
  19. Akiyama M. FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics. Br J Dermatol. 2010 Mar. 162(3):472-7. [View Abstract]
  20. Li M, Cheng R, Shi M, Liu J, Zhang G, Liu Q, et al. Analyses of FLG mutation frequency and filaggrin expression in isolated ichthyosis vulgaris (IV) and atopic dermatitis-associated IV. Br J Dermatol. 2013 Jan 5. [View Abstract]
  21. Perusquía-Ortiz AM, Oji V, Sauerland MC, Tarinski T, Zaraeva I, Seller N, et al. Complete filaggrin deficiency in ichthyosis vulgaris is associated with only moderate changes in epidermal permeability barrier function profile. J Eur Acad Dermatol Venereol. 2013 Jan 7. [View Abstract]
  22. Blunder S, Kõks S, Kõks G, Reimann E, Hackl H, Gruber R, et al. Enhanced Expression of Genes Related to Xenobiotic Metabolism in the Skin of Patients with Atopic Dermatitis but Not with Ichthyosis Vulgaris. J Invest Dermatol. 2018 Jan. 138 (1):98-108. [View Abstract]
  23. Dar NR, Raza N, Khan A, Amin MU. Paraneoplastic Addisonian pigmentation and acquired ichthyosis as presenting features of multiple myeloma. J Coll Physicians Surg Pak. 2011 Jan. 21(1):40-2. [View Abstract]
  24. Biver-Dalle C, Gil H, Meaux-Ruault N, et al. [Acquired ichthyosis and livedoid palmoplantar keratoderma: Two unusual skin manifestations of systemic lupus erythematosus.]. Rev Med Interne. 2011 Mar 21. [View Abstract]
  25. López Aventín D, Gallardo F, Yébenes M, Lloreta J, Pujol RM. Acquired ichthyosis associated with primary cutaneous CD30+ lymphoproliferative disorders. Eur J Dermatol. 2014 Feb 3. [View Abstract]
  26. Patsatsi A, Kyriakou A, Karavasilis V, Tsatsou F, Lazaridis G, Kalabalikis D, et al. Acquired ichthyosis triggered by an osseous hemangiopericytoma: a case report and review of the literature. Case Rep Dermatol. 2014 Jan. 6(1):10-5. [View Abstract]
  27. London RD, Lebwohl M. Acquired ichthyosis and hyperparathyroidism. J Am Acad Dermatol. 1989 Oct. 21(4 Pt 1):801-2. [View Abstract]
  28. Spelman LJ, Strutton GM, Robertson IM, Weedon D. Acquired ichthyosis in bone marrow transplant recipients. J Am Acad Dermatol. 1996 Jul. 35(1):17-20. [View Abstract]
  29. Kaplan MH, Sadick NS, McNutt NS, Talmor M, Coronesi M, Hall WW. Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse. J Am Acad Dermatol. 1993 Nov. 29(5 Pt 1):701-8. [View Abstract]
  30. Lee HW, Ahn SJ, Choi JC, et al. Acquired ichthyosis associated with an overlap syndrome of systemic sclerosis and systemic lupus erythematosus. J Dermatol. 2006 Jan. 33(1):52-4. [View Abstract]
  31. Urrutia S, Vazquez F, Requena L, Sanchez Yus E. Acquired ichthyosis associated with dermatomyositis. J Am Acad Dermatol. 1987 Mar. 16(3 Pt 1):627-9. [View Abstract]
  32. Roselino AM, Souza CS, Andrade JM, et al. Dermatomyositis and acquired ichthyosis as paraneoplastic manifestations of ovarian tumor. Int J Dermatol. 1997 Aug. 36(8):611-4. [View Abstract]
  33. Ennibi K, Rabhi M, Al Bouzidi A, et al. [Acquired ichthyosis revealing an Hodgkin's disease]. Rev Med Interne. 2008 May. 29(5):418-20. [View Abstract]
  34. Parsons WB Jr, Flinn JH. Reduction of serum cholesterol levels and beta-lipoprotein cholesterol levels by nicotinic acid. AMA Arch Intern Med. 1959 May. 103(5):783-90. [View Abstract]
  35. Williams ML, Feingold KR, Grubauer G, Elias PM. Ichthyosis induced by cholesterol-lowering drugs. Implications for epidermal cholesterol homeostasis. Arch Dermatol. 1987 Nov. 123(11):1535-8. [View Abstract]
  36. Poulsen J. Hair loss, depigmentation of hair, ichthyosis, and blepharoconjunctivitis produced by dixyrazine. Acta Derm Venereol. 1981. 61(1):85-8. [View Abstract]
  37. Caver CV. Clofazimine-induced ichthyosis and its treatment. Cutis. 1982 Apr. 29(4):341-3. [View Abstract]
  38. Oji V, Hautier JM, Ahvazi B, et al. Bathing suit ichthyosis is caused by transglutaminase-1 deficiency: evidence for a temperature-sensitive phenotype. Hum Mol Genet. 2006 Nov 1. 15(21):3083-97. [View Abstract]
  39. Gruber R, Sugarman JL, Crumrine D, Hupe M, Mauro TM, Mauldin EA, et al. Sebaceous gland, hair shaft, and epidermal barrier abnormalities in keratosis pilaris with and without filaggrin deficiency. Am J Pathol. 2015 Apr. 185(4):1012-21. [View Abstract]
  40. Singh M, Pawar M. Eyelash length for the diagnosis of atopic dermatitis and ichthyosis vulgaris in children-a case control study. Eur J Pediatr. 2018 Jun. 177 (6):955-960. [View Abstract]
  41. Cather JC, Cohen PR. Ichthyosiform sarcoidosis. J Am Acad Dermatol. 1999 May. 40(5 Pt 2):862-5. [View Abstract]
  42. Matarasso SL, Bruce S. Ichthyosiform sarcoidosis: report of a case. Cutis. 1991 Jun. 47(6):405-8. [View Abstract]
  43. Grahovac M, Budimcic D. Unrecognized dermatophyte infection in ichthyosis vulgaris. Acta Dermatovenerol Croat. 2009. 17(2):127-30. [View Abstract]
  44. Zhang Q, Si N, Liu Y, Zhang D, Wang R, Zhang Y, et al. Steroid sulfatase and filaggrin mutations in a boy with severe ichthyosis, elevated serum IgE level and moyamoya syndrome. Gene. 2017 Jul 11. [View Abstract]
  45. Tadini G, Giustini S, Milani M. Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream. Curr Med Res Opin. 2011 Dec. 27(12):2279-84. [View Abstract]
  46. Benintende C, Boscaglia S, Dinotta F, Lacarrubba F, Micali G. Treatment of ichthyosis vulgaris with a urea-based emulsion: videodermatoscopy and confocal microscopy evaluation. G Ital Dermatol Venereol. 2017 Dec. 152 (6):555-559. [View Abstract]
  47. Friedman AJ, von Grote EC, Meckfessel MH. Urea: A Clinically Oriented Overview from Bench to Bedside. J Drugs Dermatol. 2016 May 1. 15 (5):633-9. [View Abstract]
  48. Haas AA, Arndt KA. Selected therapeutic applications of topical tretinoin. J Am Acad Dermatol. 1986 Oct. 15(4 Pt 2):870-7. [View Abstract]
  49. Hofmann B, Stege H, Ruzicka T, Lehmann P. Effect of topical tazarotene in the treatment of congenital ichthyoses. Br J Dermatol. 1999 Oct. 141(4):642-6. [View Abstract]
  50. Shi VY, Tran K, Lio PA. A Comparison of Physicochemical Properties of a Selection of Modern Moisturizers: Hydrophilic Index and pH. J Drugs Dermatol. 2012 May 1. 11(5):633-6. [View Abstract]
  51. Osawa R, Akiyama M, Shimizu H. Filaggrin gene defects and the risk of developing allergic disorders. Allergol Int. 2011 Mar. 60(1):1-9. [View Abstract]
  52. Hoppe T, Winge MC, Bradley M, Nordenskjöld M, Vahlquist A, Törmä H, et al. Moisturizing treatment of patients with atopic dermatitis and ichthyosis vulgaris improves dry skin, but has a modest effect on gene expression regardless of FLG genotype. J Eur Acad Dermatol Venereol. 2013 Dec 12. [View Abstract]
  53. Süßmuth K, Traupe H, Metze D, Oji V. Ichthyoses in everyday practice: management of a rare group of diseases. J Dtsch Dermatol Ges. 2020 Mar. 18 (3):225-243. [View Abstract]

Hereditary ichthyosis vulgaris with thick scaling of the anterior shins.

Hematoxylin and eosin staining of acquired ichthyosis vulgaris in an adult. Shows epidermal atrophy with thinning of the granular layer. No dermal infiltrate is evident.

Hereditary ichthyosis vulgaris with thick scaling of the anterior shins.

Hematoxylin and eosin staining of acquired ichthyosis vulgaris in an adult. Shows epidermal atrophy with thinning of the granular layer. No dermal infiltrate is evident.